semaglutide trial adolescents obesity 2022 GLP-1 prescribing among teens with SCALE KIDS Trial: Evaluating Liraglutide's

This is where many people are searching for the newer peptide still in clinical trials -Retatrutide

Gong Q, Zhang P, Wang J et al (2019) Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study

LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al

Role of Escherichia coli curli operons in directing amyloid fiber formation

Reduction of GBB with L-CN may lead to impaired conversion of L-CN to acylcarnitines 42 , which have been shown to be anticoagulants inhibiting factor Xa by metabolomics in VTE 10